No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Cardiomyopathy, Dilated / diagnosis*
-
Cardiomyopathy, Dilated / drug therapy
-
Cardiomyopathy, Dilated / epidemiology*
-
Comorbidity
-
Energy Metabolism / physiology
-
Female
-
Humans
-
Insulin Resistance*
-
Male
-
Prevalence
-
Prognosis
-
Risk Assessment
-
Severity of Illness Index
-
Survival Rate
-
Sympathetic Nervous System / physiopathology
Substances
-
Adrenergic beta-Antagonists